ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,022Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1107

$1.4M Total Retail Price of All Prescriptions

Rank: 38 out of 1107

839 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 839 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 839 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 14,685 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,234 635 S3 1 1
OMEPRAZOLE 901 501 2 4
LISINOPRIL 777 477 3 2
FUROSEMIDE 752 573 4 7
LEVOTHYROXINE SODIUM 688 388 5 3
METFORMIN HCL 543 290 6 8
GABAPENTIN 506 262 7 9
SIMVASTATIN 500 281 8 5
IBUPROFEN 477 39 9 63
WARFARIN SODIUM 452 392 10 15
RISPERIDONE 398 220 11 79
CITALOPRAM HBR 388 234 12 17
POTASSIUM CHLORIDE 352 245 13 14
ATENOLOL 351 219 14 19
AMLODIPINE BESYLATE 312 244 15 6
RANITIDINE HCL 303 116 16 21
CLONIDINE HCL 297 186 17 53
LOSARTAN POTASSIUM 253 191 18 29
TRAMADOL HCL 250 179 19 26
METOPROLOL TARTRATE 250 193 19 10
MELOXICAM 238 111 21 25
PRAVASTATIN SODIUM 236 148 22 12
HYDROXYZINE PAMOATE 235 12 R 23 152
SERTRALINE HCL 233 163 24 20
CARISOPRODOL 232 62 R 25 146
POLYETHYLENE GLYCOL 3350 228 176 26 46
QUETIAPINE FUMARATE 212 59 27 94
OXYBUTYNIN CHLORIDE 207 66 28 171
PROMETHAZINE HCL 205 91 R 29 44
LANTUS 203 127 30 49
DONEPEZIL HCL 201 173 31 32
CARVEDILOL 197 110 32 27
DIGOXIN 180 122 33 52
INSULIN SYRINGE 168 82 34 78
ZOLPIDEM TARTRATE 167 98 35 22
OXYCODONE HCL-ACETAMINOPHEN 166 82 S2 36 93
NOVOLOG 156 86 37 127
CLOPIDOGREL 154 122 38 28
TRAZODONE HCL 151 54 39 33
TAMSULOSIN HCL 148 84 40 30
CARBIDOPA-LEVODOPA 147 114 41 122
HALOPERIDOL 144 55 42 225
AMITRIPTYLINE HCL 143 75 R 43 48
NAMENDA 139 139 44 42
FENTANYL 138 138 S2 45 105
PAROXETINE HCL 135 92 46 45
FLUTICASONE PROPIONATE 131 51 47 38
ADVAIR DISKUS 130 66 48 54
DIVALPROEX SODIUM ER 128 14 49 216
PLAVIX 127 99 50 39
ROPINIROLE HCL 125 90 51 69
MIRTAZAPINE 124 69 52 61
NITROFURANTOIN 119 77 53 238
HYDROCHLOROTHIAZIDE 119 64 53 11
MEGESTROL ACETATE 118 82 R 55 178
LOVAZA 118 14 55 101
DIVALPROEX SODIUM 116 26 57 96
ATORVASTATIN CALCIUM 115 81 58 13
PANTOPRAZOLE SODIUM 113 85 59 30
GEMFIBROZIL 111 39 60 107
NEXIUM 110 95 61 18
OLANZAPINE 108 50 62 176
BENZTROPINE MESYLATE 107 34 R 63 174
PREDNISONE 107 60 63 40
LACTULOSE 104 63 65 89
PHENYTOIN SODIUM EXTENDED 102 17 66 147
NOVOLIN R 102 74 66 187
GLIMEPIRIDE 100 41 68 43
HYDROXYZINE HCL 100 54 R 68 162
FLUOXETINE HCL 95 25 70 47
SINGULAIR 93 38 71 65
LEVOFLOXACIN 93 71 71 71
AZITHROMYCIN 93 45 71 35
METOPROLOL SUCCINATE 92 91 74 16
RISPERDAL CONSTA 92 44 74 263
DICLOFENAC SODIUM 90 35 76 74
LITHIUM CARBONATE 90 0 76 306
CRESTOR 90 70 76 23
DIOVAN 90 65 76 51
ABILIFY 87 45 80 170
OXYBUTYNIN CHLORIDE ER 86 55 81 179
PROAIR HFA 83 11 82 37
TRICOR 81 35 83 95
BUPROPION HCL SR 80 0 84 190
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 47 85 88
FLUPHENAZINE HCL 76 12 85 413
KLOR-CON 10 75 40 87 143
DOXEPIN HCL 74 27 88 180
FAMOTIDINE 74 40 88 111
ALENDRONATE SODIUM 72 58 90 41
ISOSORBIDE MONONITRATE ER 70 51 91 34
ESTRADIOL 69 38 R 92 151
LOPERAMIDE 67 28 93 229
METOCLOPRAMIDE HCL 67 45 93 116
NAPROXEN 66 14 95 80
NYSTATIN 66 28 95 110
DOXAZOSIN MESYLATE 66 58 95 92
ALPRAZOLAM 65 31 98 87
HYDRALAZINE HCL 65 37 98 99
SPIRONOLACTONE 65 45 98 72
VENLAFAXINE HCL 65 30 98 193
ATENOLOL-CHLORTHALIDONE 64 54 102 189
LOVASTATIN 64 37 102 55
CEPHALEXIN 63 42 104 81
CEFPROZIL 63 46 104 305
TRIAMCINOLONE ACETONIDE 62 26 106 137
SEROQUEL 62 12 106 182
ENDOCET 61 34 S2 108 91
OXYCODONE-ACETAMINOPHEN 60 38 S2 109 104
GENERLAC 60 60 109 281
CLOTRIMAZOLE-BETAMETHASONE 59 31 111 198
CIPROFLOXACIN HCL 59 41 111 59
ZETIA 59 44 111 76
SPIRIVA 59 18 111 57
COLESTIPOL HCL 57 22 115 259
MONTELUKAST SODIUM 57 23 115 118
EVISTA 55 55 117 135
NYSTATIN-TRIAMCINOLONE 54 39 118 454
TRIHEXYPHENIDYL HCL 51 12 R 119 378
CYCLOBENZAPRINE HCL 51 23 R 119 56
ALLOPURINOL 51 48 119 36
LEVETIRACETAM 51 0 119 141
CYMBALTA 51 26 119 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.